Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically...
/PRNewswire/ -- DelveInsight's 'Soft Tissue Sarcoma Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and pipeline...
The prevalence of soft tissue sarcoma has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of soft tissue sarcoma and the
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 7,695 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $7.68, for a total value of $59,097.60. Following the completion of the transaction, the chairman now owns 1,833,848 shares of the company’s […]
Aadi Bioscience (NASDAQ:AADI – Get Rating) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, May 10th. Analysts expect the company to announce earnings of ($0.58) per share for the quarter. Aadi Bioscience Stock Performance AADI traded down $0.11 during trading on Thursday, hitting $7.62. The stock had a […]